default author photo

Lizza E.L. Hendriks

Maastricht University

SCHOLARLY PAPERS

4

DOWNLOADS

256

TOTAL CITATIONS

1

Scholarly Papers (4)

1.

High Dose Osimertinib in Patients with Advanced Stage EGFR Exon 20 Mutation-Positive NSCLC: Results from the Phase 2 Multicenter POSITION20 Trial

Number of pages: 21 Posted: 25 Feb 2022
University of Groningen - Department of Pulmonology, affiliation not provided to SSRN, Maastricht University, University of Groningen - Department of Pulmonary Diseases, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam, Amphia Hospital, Netherlands Cancer Institute, Radboud University Nijmegen - Department of Pulmonary Diseases and University of Groningen - University Medical Center Groningen
Downloads 90 (753,595)

Abstract:

Loading...

Non-small cell lung cancer, epidermal growth factor receptor, tyrosine kinase inhibitors, exon 20 mutation, Osimertinib

2.

AI-Derived Longitudinal and Multi-Dimensional CT Classifier for Non-Small Cell Lung Cancer to Optimize Neoadjuvant Chemoimmunotherapy Decision: A Multicentre Retrospective Study

Number of pages: 49 Posted: 14 Jul 2025
Zhengzhou University, Southern Medical University - Department of Radiology, Guangdong Academy of Medical Sciences - Department of Radiology, Wuhan Union Hospital, Southern Medical University - Department of Radiology, Southern Medical University - Department of Radiology, Southern Medical University - Department of Radiology, Zhengzhou University, Zhengzhou University, Guangdong Academy of Medical Sciences - Department of Radiology, Wuhan Union Hospital, Maastricht University, Maastricht University - GROW School for Oncology and Reproduction, Maastricht University, Maastricht University, Guangdong Academy of Medical Sciences - Guangdong Provincial People's Hospital, Zhengzhou University - Department of Thoracic Surgery, Guangdong Academy of Medical Sciences - Department of Radiology and Guangdong Academy of Medical Sciences
Downloads 87 (759,537)

Abstract:

Loading...

non-small cell lung cancer, neoadjuvant chemoimmunotherapy, radiomics, deep learning, habitat imaging, Longitudinal CT

3.

Osimertinib Dose Optimization Guided by Therapeutic Drug Monitoring in Patients with Egfr-Mutated Advanced Non-Small Cell Lung Cancer: A Case Series

Number of pages: 16 Posted: 26 Apr 2025
Maastricht University, Zuyderland Medical Center, Zuyderland Medical Center, Maastricht University, Department of Clinical Pharmacy, Pharmacology & Toxicology. Zuyderland Medical Center, affiliation not provided to SSRN and affiliation not provided to SSRN
Downloads 46 (1,109,210)
Citation 1

Abstract:

Loading...

Osimertinib, Non-small cell lung cancer, TDM, case series

4.

Model-Informed Approaches to Develop Cost-Saving Dosing Strategies for Pembrolizumab

Number of pages: 20 Posted: 17 Apr 2026
affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, Erasmus University Rotterdam (EUR) - Department of Pulmonary Medicine, affiliation not provided to SSRN, Netherlands Cancer Institute Antoni van Leeuwenhoek, affiliation not provided to SSRN, Leiden University Medical Centre, Leiden University - Leiden University Medical Center (LUMC), Amsterdam Academic Medical Center, University of Groningen - Department of Pulmonary Diseases, Maastricht University, affiliation not provided to SSRN, affiliation not provided to SSRN, affiliation not provided to SSRN, University of Groningen - University Medical Center Groningen, affiliation not provided to SSRN, Leiden University - Department of Clinical Pharmacy and Toxicology, Leiden University - Department of Clinical Pharmacy and Toxicology and Radboud University Nijmegen - Department of Pharmacy and Radboud Center for Infectious Diseases
Downloads 33 (1,359,097)

Abstract:

Loading...

pembrolizumab, pharmacokinetics, modeling and simulation, cost-effectiveness